CTOs on the Move

HolaDoctor

www.holadoctor.net

 
HolaDoctor is a global leader in Hispanic Health. Founded in 1999, HolaDoctor has a long history engaging the Hispanic community on the importance of healthy lifestyles, health insurance, access to care, and early detection and aggressive management of chronic illnesses and risk factors. HolaDoctor has an unparalleled understanding of the Hispanic healthcare consumer, the Healthcare Industry and the business opportunities created by Healthcare Reform around the Hispanic market.  
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Similar Companies

Draeger

Draeger Safety Pacific is a supplier of high quality respiratory protection, including single and dual filter masks as well as different material options to suit all customer requirements.

AJ Medical

AJ Medical is a Clearwater, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Westpak Inc

Westpak Inc is a San Jose, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Hillcrest Healthcare System

Hillcrest Healthcare System is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Knoxville, TN. To find more information about Hillcrest Healthcare System, please visit www.hillcrest.com

Delphinus Medical Technologies

Delphinus Medical Technologies, Inc. is an innovation leader in advanced ultrasound development, introducing a dynamic new technique to image the breast with the use of sound and water. Delphinus is committed to creating improved imaging methods that assist medical professionals to better define and diagnose breast disease, while establishing a better patient experience that can be available for all women, regardless of age, without the concern of radiation or pain. Headquartered in Plymouth, MI, Delphinus is the first company to design and manufacture a whole breast ultrasound system that utilizes a ring transducer to transmit and receive ultrasound signals. Known as SoftVue™, three critical sound characteristics are measured and refined through proprietary algorithms, advancing this technology far beyond traditional b-mode ultrasound. By collecting and defining reflection, sound speed, and attenuation data in a 360° orientation, data are gathered and reconstructed in tomographic coronal planes, providing an enriched image set presented for cross-sectional review. SoftVue has received FDA clearance for diagnostic imaging purposes and is not intended for use as a replacement for screening mammography. Delphinus was formed in 2010 as a spin-out of Karmanos Cancer Institute [KCI] in Detroit, MI. Created by Peter Littrup, MD of Karmanos and Neb Duric, PhD of Wayne State University Detroit, MI the SoftVue technology presents a new imaging paradigm in breast disease assessment. Karmanos Cancer Institute has served as a primary investigational site for case collection and clinical studies. Delphinus holds numerous patents and proprietary assets for its innovative and scientifically-advanced works and is poised to usher in a new era of breast imaging.